Production (Stage)
BridgeBio Pharma, Inc.
BBIO
$40.07
-$1.07-2.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.02% | 56.62% | -50.98% | 16.67% | 5.78% |
| Total Receivables | -51.05% | 169.67% | -90.75% | -92.34% | 2,088.40% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 14.31% | 27.72% | 27.83% | 38.21% | 11.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2,362.60% | -77.03% | 794.24% | 599.49% | -99.49% |
| Total Current Assets | -11.26% | 50.90% | -24.35% | 42.36% | 41.74% |
|
|
|||||
| Total Current Assets | -11.26% | 50.90% | -24.35% | 42.36% | 41.74% |
| Net Property, Plant & Equipment | -28.78% | -35.60% | -30.37% | -25.17% | -19.22% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 8.09% | -9.09% | -8.89% | -8.69% | -8.51% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -19.85% | -13.46% | 11.64% | -3.56% | -0.22% |
| Total Assets | 3.80% | 68.26% | 1.52% | 57.72% | 35.75% |
|
|
|||||
| Total Accounts Payable | 482.17% | -9.73% | 198.81% | 367.89% | 16.00% |
| Total Accrued Expenses | -5.69% | 6.08% | 23.37% | 5.27% | 37.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.63% | 9.16% | 11.19% | 22.43% | 23.68% |
| Total Finance Division Other Current Liabilities | -29.08% | 33.92% | 31.48% | 27.51% | 147.73% |
| Total Other Current Liabilities | -29.08% | 33.92% | 31.48% | 27.51% | 147.73% |
| Total Current Liabilities | 7.51% | 7.34% | 31.26% | 22.02% | 46.46% |
|
|
|||||
| Total Current Liabilities | 7.51% | 7.34% | 31.26% | 22.02% | 46.46% |
| Long-Term Debt | 7.70% | -0.31% | -0.10% | -0.08% | 0.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -40.76% | -47.71% | -40.55% | -35.33% | -30.30% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2,414.81% | 5,203.62% | 61.26% | 30.92% | 17.05% |
| Total Liabilities | 33.62% | 25.84% | 1.87% | 1.25% | 2.55% |
|
|
|||||
| Common Stock & APIC | 6.45% | 28.50% | 28.53% | 64.08% | 64.54% |
| Retained Earnings | -25.73% | -20.92% | -18.34% | -20.49% | -26.16% |
| Treasury Stock & Other | -17.56% | -0.01% | -0.01% | -0.02% | 0.01% |
| Total Common Equity | -57.06% | -8.39% | -1.85% | 19.76% | 14.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -57.06% | -8.39% | -1.85% | 19.76% | 14.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -23.20% | -12.20% | -16.50% | -12.54% | 5.13% |
| Total Equity | -58.04% | -8.57% | -2.07% | 19.82% | 14.56% |
|
|
|||||